机构：[1]Department of Immunology and Research Center of Basic MedicalSciences, Key Laboratory of Immune Microenvironment and Diseasesof Educational Ministry of China, Tianjin Key Laboratory of Cellularand Molecular Immunology, Tianjin Medical University, 300070Tianjin, China[2]Institute of Integrative Medicines for AcuteAbdominal Diseases, Tianjin Nankai Hospital, 300100 Tianjin, China[3]Department of Physics, The University of Texas at Arlington,Arlington, TX 76019-0059, USA[4]Guangdong Province KeyLaboratory for Biotechnology Drug Candidates, Institute of BasicMedical Sciences, School of Life Sciences and Biopharmaceutics,Guangdong Pharmaceutical University, Guangzhou, China[5]Department of Dermatovenereology, West China Hospital, SichuanUniversity, Chengdu, Sichuan Province, China四川大学华西医院[6]Department ofRadiology, The University of Texas Southwestern Medical Center,Dallas, TX, USA
National Natural Science Foundation of China
through No. 81872320, 31600730, 81602496, and 81272317 and the Innovation and
University Promotion Project of Guangdong Pharmaceutical University through No.
2017KCXTD020
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2020]版：
大类|1 区医学
小类|1 区生化与分子生物学1 区细胞生物学
最新[2023]版：
大类|1 区医学
小类|1 区生化与分子生物学1 区细胞生物学
第一作者：
第一作者机构：[1]Department of Immunology and Research Center of Basic MedicalSciences, Key Laboratory of Immune Microenvironment and Diseasesof Educational Ministry of China, Tianjin Key Laboratory of Cellularand Molecular Immunology, Tianjin Medical University, 300070Tianjin, China[2]Institute of Integrative Medicines for AcuteAbdominal Diseases, Tianjin Nankai Hospital, 300100 Tianjin, China
共同第一作者：
通讯作者：
通讯机构：[1]Department of Immunology and Research Center of Basic MedicalSciences, Key Laboratory of Immune Microenvironment and Diseasesof Educational Ministry of China, Tianjin Key Laboratory of Cellularand Molecular Immunology, Tianjin Medical University, 300070Tianjin, China[4]Guangdong Province KeyLaboratory for Biotechnology Drug Candidates, Institute of BasicMedical Sciences, School of Life Sciences and Biopharmaceutics,Guangdong Pharmaceutical University, Guangzhou, China
推荐引用方式(GB/T 7714)：
Qi Zhang,Xiangdong Guo,Yingnan Cheng,et al.Use of copper-cysteamine nanoparticles to simultaneously enable radiotherapy, oxidative therapy and immunotherapy for melanoma treatment.[J].Signal transduction and targeted therapy.2020,5(1):58.doi:10.1038/s41392-020-0156-4.
APA：
Qi Zhang,Xiangdong Guo,Yingnan Cheng,Lalit Chudal,Nil Kanatha Pandey...&Rongxin Zhang.(2020).Use of copper-cysteamine nanoparticles to simultaneously enable radiotherapy, oxidative therapy and immunotherapy for melanoma treatment..Signal transduction and targeted therapy,5,(1)
MLA：
Qi Zhang,et al."Use of copper-cysteamine nanoparticles to simultaneously enable radiotherapy, oxidative therapy and immunotherapy for melanoma treatment.".Signal transduction and targeted therapy 5..1(2020):58
医学